Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ella Zomer

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
Neurology|September 16, 2020
The costs of epilepsy in Australia: A productivity-based analysisEmma Foster, Zhibin Chen, Ella Zomer, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|September 29, 2017
Adherence and Persistence Among Statin Users Aged 65 Years and Over: A Systematic Review and Meta-analysisRichard Ofori-Asenso, Avtar Jakhu, Ella Zomer, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|January 24, 2018
A Systematic Review and Meta-analysis of the Factors Associated With Nonadherence and Discontinuation of Statins Among People Aged ≥65 YearsRichard Ofori-Asenso, Avtar Jakhu, Andrea J Curtis, et al.
European Journal of Preventive Cardiology|March 9, 2021
Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029Clara Marquina, Stella Talic, Sandra Vargas-Torres, et al.
Cardiovascular Drugs and Therapy|June 7, 2021
Switching, Persistence and Adherence to Statin Therapy: a Retrospective Cohort Study Using the Australian National Pharmacy DataStella Talic, Clara Marquina, Richard Ofori-Asenso, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 3, 2024
The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetesElla Zomer, Jennifer Zhou, Adam J Nelson, et al.
Current Problems in Cardiology|June 10, 2021
Trends in the Utilization of Lipid-Lowering Medications in Australia: An Analysis of National Pharmacy Claims DataStella Talic, Clara Marquina Hernandez, Richard Ofori-Asenso, et al.
Diabetes Research and Clinical Practice|August 7, 2025
Adherence patterns to cardiovascular medications in people with type 2 diabetes mellitus: a retrospective cohort study using group-based trajectory analysis in primary careSri Chodapuneedi, Jia Wei Koh, Zhomart Orman, et al.
Diabetes Care|September 26, 2022
Nationally Subsidized Continuous Glucose Monitoring: A Cost-effectiveness AnalysisAnthony J Pease, Sophia Zoungas, Emily Callander, et al.
Diabetes Technology & Therapeutics|October 13, 2025
Automated Insulin Delivery Is Associated with Reduced Hospital Admissions and Costs for Acute Diabetes Complications in Children with Type 1 DiabetesMercedes J Burnside, Katrina Ellis, Timothy W Jones, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Neurology|September 16, 2020
The costs of epilepsy in Australia: A productivity-based analysisEmma Foster, Zhibin Chen, Ella Zomer, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|September 29, 2017
Adherence and Persistence Among Statin Users Aged 65 Years and Over: A Systematic Review and Meta-analysisRichard Ofori-Asenso, Avtar Jakhu, Ella Zomer, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|January 24, 2018
A Systematic Review and Meta-analysis of the Factors Associated With Nonadherence and Discontinuation of Statins Among People Aged ≥65 YearsRichard Ofori-Asenso, Avtar Jakhu, Andrea J Curtis, et al.
European Journal of Preventive Cardiology|March 9, 2021
Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029Clara Marquina, Stella Talic, Sandra Vargas-Torres, et al.
Cardiovascular Drugs and Therapy|June 7, 2021
Switching, Persistence and Adherence to Statin Therapy: a Retrospective Cohort Study Using the Australian National Pharmacy DataStella Talic, Clara Marquina, Richard Ofori-Asenso, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 3, 2024
The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetesElla Zomer, Jennifer Zhou, Adam J Nelson, et al.
Current Problems in Cardiology|June 10, 2021
Trends in the Utilization of Lipid-Lowering Medications in Australia: An Analysis of National Pharmacy Claims DataStella Talic, Clara Marquina Hernandez, Richard Ofori-Asenso, et al.
Diabetes Research and Clinical Practice|August 7, 2025
Adherence patterns to cardiovascular medications in people with type 2 diabetes mellitus: a retrospective cohort study using group-based trajectory analysis in primary careSri Chodapuneedi, Jia Wei Koh, Zhomart Orman, et al.
Diabetes Care|September 26, 2022
Nationally Subsidized Continuous Glucose Monitoring: A Cost-effectiveness AnalysisAnthony J Pease, Sophia Zoungas, Emily Callander, et al.
Diabetes Technology & Therapeutics|October 13, 2025
Automated Insulin Delivery Is Associated with Reduced Hospital Admissions and Costs for Acute Diabetes Complications in Children with Type 1 DiabetesMercedes J Burnside, Katrina Ellis, Timothy W Jones, et al.
Pageof 12